Rare‐Variant Burden across Lysosomal Genes Implicates Sialylation and Ganglioside Metabolism in Parkinson's Disease
Authors:
Open Access
- 10 June 2026
- journal article
- Published by Wiley in Movement Disorders
- Vol. 41 (9) , 2349-2356
Abstract
Background: Lysosomal dysfunction is central to Parkinson's disease (PD) pathogenesis, with GBA1 representing the strongest established genetic risk factor. Numerous other genes involved in lysosomal sphingolipid, glycosphingolipid, and ceramide metabolism have been proposed as contributors to PD, highlighting the need for genetic analyses across these pathways. Objectives: The aim was to evaluate the contribution of rare variants across lysosomal genes to PD risk. Methods: We analyzed rare variants (minor allele frequency ≤0.01) across 36 lysosomal genes in 8267 individuals with PD and 68,208 controls, including 793 early‐onset PD (≤50 years) cases. Targeted sequencing was performed in four cohorts at McGill University (3456 cases and 2664 controls) and combined with whole‐genome sequencing data from the United Kingdom (UK) Biobank (2848 cases, 62,451 controls) and the Accelerating Medicines Partnership‐PD cohort (1963 cases, 3093 controls). Associations were tested using Sequence Kernel Association Test‐Optimal across variant classes (rare variants, nonsynonymous, loss‐of‐function, and predicted damaging variants with combined annotation‐dependent depletion score >20), followed by meta‐analysis across cohorts. Domain‐level analyses were performed for variants located within protein domains. False discovery rate (FDR) correction was applied. Results: Meta‐analysis identified a significant association between rare variants in ST3GAL3 and Parkinson's disease (Pfdr = 0.04). Domain‐based analyses showed enrichment of nonsynonymous variants within the β‐acetyl‐hexosaminidase–like domain of HEXA ( P = 8.0 × 10 −4 ), although this signal did not survive correction (Pfdr = 0.154). In early‐onset PD, domain‐based analyses identified significant associations in NAGLU (Pfdr = 7.3 × 10 −6 ) and ST3GAL5 (Pfdr = 0.03). Conclusions: Rare variants across multiple lysosomal pathways, particularly those related to sialylation, ganglioside metabolism, ceramide biology, and lysosomal proteolysis, may contribute to PD susceptibility beyond GBA1 , highlighting pathways for future replication and investigation. © 2026 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.Keywords
Funding Information
- Michael J. Fox Foundation for Parkinson's Research
- Consortium canadien en neurodégénérescence associée au vieillissement
- Canada First Research Excellence Fund
- Parkinson Canada
- Parkinson's Foundation (K02NS080915)
- National Institutes of Health (UL1 TR000040)
- Brookdale Foundation Group
- McGill University
This publication has 46 references indexed in Scilit:
- Association of Rare Variants in ARSA with Parkinson's DiseaseMovement Disorders, 2023
- Lysosomal functions and dysfunctions: Molecular and cellular mechanisms underlying Gaucher disease and its association with Parkinson diseaseAdvanced Drug Delivery Reviews, 2022
- Rare Variants in Specific Lysosomal Genes Are Associated With Parkinson's DiseaseMovement Disorders, 2020
- Increased yield of full GBA sequencing in Ashkenazi Jews with Parkinson's diseaseEuropean Journal of Medical Genetics, 2019
- Accumulated α-synuclein affects the progression of GM2 gangliosidosesExperimental Neurology, 2016
- MDS clinical diagnostic criteria for Parkinson's diseaseMovement Disorders, 2015
- Optimal Unified Approach for Rare-Variant Association Testing with Application to Small-Sample Case-Control Whole-Exome Sequencing StudiesThe American Journal of Human Genetics, 2012
- ST3GAL3 Mutations Impair the Development of Higher Cognitive FunctionsThe American Journal of Human Genetics, 2011
- Gaucher Disease Glucocerebrosidase and α-Synuclein Form a Bidirectional Pathogenic Loop in SynucleinopathiesCell, 2011
- Crystallographic Structure of Human β-Hexosaminidase A: Interpretation of Tay-Sachs Mutations and Loss of GM2 Ganglioside HydrolysisJournal of Molecular Biology, 2006